re: Ann: Phylogica Signs Collaboration and Li... With 3 majors now involved with PYC company and the chances of success with at least one if not more of them being a reasonable punt the more risk averse investors will now get in.
They tend to be longer term and will be happier to wait on that success. Should form a more solid base to the sp this time around.
They will also note that Roche has used some very positive words recently with respect to initial results, making the likelihood of a second stage investigation involving more money up front is likely.
Ann: Phylogica Signs Collaboration and Licensing , page-12
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.005(0.37%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $211.9K | 152.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4103 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 2028 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |